Jin Yang Wen
Career history of Jin Yang Wen
Former positions of Jin Yang Wen
| Companies | Position | Start | End |
|---|---|---|---|
Aldea Pharmaceuticals, Inc.
 Aldea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aldea Pharmaceuticals, Inc. develops novel enzyme activators to enhance the removal of toxic aldehydes. It targets Aldehyde metabolism dysfunction which is associated with a variety of diseases from acute alcohol toxicity to orphan indications such as Fanconi anemia. The company was founded by Daria Mochly-Rosen, Che-Hong Chen and Wenjin Yang in 2011 and is headquartered in Redwood City, CA. | Founder | - | - |
| Corporate Officer/Principal | - | - | |
| EIGER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
| FORESEE PHARMACEUTICALS CO., LTD. | Corporate Officer/Principal | 20/09/2015 | - |
Training of Jin Yang Wen
| University of California | Doctorate Degree |
| Chinese Culture University | Undergraduate Degree |
Statistics
International
| United States | 4 |
| Taiwan | 3 |
Operational
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| FORESEE PHARMACEUTICALS CO., LTD. | Health Technology |
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Aldea Pharmaceuticals, Inc.
Aldea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aldea Pharmaceuticals, Inc. develops novel enzyme activators to enhance the removal of toxic aldehydes. It targets Aldehyde metabolism dysfunction which is associated with a variety of diseases from acute alcohol toxicity to orphan indications such as Fanconi anemia. The company was founded by Daria Mochly-Rosen, Che-Hong Chen and Wenjin Yang in 2011 and is headquartered in Redwood City, CA. | Health Technology |
- Stock Market
- Insiders
- Jin Yang Wen
- Experience
